Study of Rasagiline in Parkinson's Disease Patients Using Levodopa
- Study Title
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
- Teva Identifier
- TV-1012/133
- ClinicalTrials.gov Identifier
- NCT00203034
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: rasagiline mesylate | Drug: 1.0 mg rasagiline mesylate | Other: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 30 Years and older
- Trial Duration
- 05/01/2000 - 01/01/2003
- Phase
- Phase 3
